| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/23/2002 | US6375981 Modified starch as a replacement for gelatin in soft gel films and capsules |
| 04/23/2002 | US6375980 Stabilization of lipid:DNA formulations during nebulization |
| 04/23/2002 | US6375978 Pre-annealing membrane polymer |
| 04/23/2002 | US6375975 Pharmaceutical compositions for buccal and pulmonary application |
| 04/23/2002 | US6375973 Olopatadine and emedastine and an ophthalmically acceptable polymeric quaternary ammonium compound as a preservative |
| 04/23/2002 | US6375972 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 04/23/2002 | US6375970 Administering hydrogel and polymerizing it |
| 04/23/2002 | US6375968 Encapsulated active material immobilized in hydrogel microbeads |
| 04/23/2002 | US6375963 Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof |
| 04/23/2002 | US6375960 Nanoemulsion based on ethoxylated fatty ethers or on ethoxylated fatty esters and its uses in the cosmetics, dermatological and/or ophthalmological fields |
| 04/23/2002 | US6375956 Drug delivery |
| 04/23/2002 | US6375931 Contrast agents |
| 04/23/2002 | US6375649 Substance delivery device |
| 04/23/2002 | CA2268175C Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| 04/23/2002 | CA2257106C Improvements in detection systems and methods for predicting the dissolution curve of a drug from a pharmaceutical dosage form |
| 04/23/2002 | CA2252772C Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |
| 04/23/2002 | CA2193149C Cationic therapuetic agents and delivery systems |
| 04/23/2002 | CA2166312C Compositions for nasal administration of desmopressin |
| 04/23/2002 | CA2112663C Effervescent systems using reaction doping agents |
| 04/23/2002 | CA2099771C Liposomal-polyene preliposomal powder and method for its preparation |
| 04/23/2002 | CA2072148C Tissue moisturizing composition and method |
| 04/18/2002 | WO2002031092A2 Method for the inclusion of perfume oils in washing and cleaning agents or cosmetics |
| 04/18/2002 | WO2002031025A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 04/18/2002 | WO2002030499A2 Medicament dispenser |
| 04/18/2002 | WO2002030490A2 Fluid material dispensing syringe |
| 04/18/2002 | WO2002030485A1 Embolic materials |
| 04/18/2002 | WO2002030473A1 Targeted therapeutic agents |
| 04/18/2002 | WO2002030472A2 Compositions for release of radiosensitizers, and methods of making and using the same |
| 04/18/2002 | WO2002030467A2 Pharmaceutical composition containing honey for the treatment of wounds |
| 04/18/2002 | WO2002030466A2 Pharmaceutical applications of hydrotropic agents, polymers thereof, and hydrogels thereof |
| 04/18/2002 | WO2002030463A2 Reduced-viscosity concentrated protein formulations |
| 04/18/2002 | WO2002030456A1 Targeting drug/gene carriers to irradiated tissue |
| 04/18/2002 | WO2002030455A2 Agents for the treatment of viral infections |
| 04/18/2002 | WO2002030449A1 Method of forming polypeptide particles |
| 04/18/2002 | WO2002030437A1 Citrus composition for hygiene, care or protection of teats |
| 04/18/2002 | WO2002030417A1 Medicinal suspensions containing branched amino acids |
| 04/18/2002 | WO2002030416A1 Medicinal suspensions containing branched amino acids |
| 04/18/2002 | WO2002030414A1 Compositions comprising modafinil compounds |
| 04/18/2002 | WO2002030413A1 Pharmaceutical solutions of modafinil compounds |
| 04/18/2002 | WO2002030402A2 Film for active ingredients dermal and transdermal administration |
| 04/18/2002 | WO2002030401A2 Microchip reservoir devices and facilitated corrosion of electrodes |
| 04/18/2002 | WO2002030399A2 Polymer controlled delivery of a therapeutic agent |
| 04/18/2002 | WO2002030398A2 Delayed release pharmaceutical formulations |
| 04/18/2002 | WO2002030397A1 Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors |
| 04/18/2002 | WO2002030396A1 Medication delivery devices |
| 04/18/2002 | WO2002030395A1 Topical antibiotic composition for treatment of eye infection |
| 04/18/2002 | WO2002030394A2 Medicinal aerosol formulations |
| 04/18/2002 | WO2002030393A2 Polymeric delivery formulations of leuprolide with improved efficacy |
| 04/18/2002 | WO2002030392A2 Formulation containing amoxicillin |
| 04/18/2002 | WO2002030391A2 Method for determining the release of a peptide from a sustained release polylactide formulation |
| 04/18/2002 | WO2002030389A1 Novel tiotropium-containing inhalation powder |
| 04/18/2002 | WO2002030388A2 Material for producing products having fibrinolytic and/or antibacterial properties |
| 04/18/2002 | WO2002030377A2 Product for cleaning teeth and/or the mouth |
| 04/18/2002 | WO2002030264A2 Microchip reservoir devices using wireless transmission of power and data |
| 04/18/2002 | WO2002030213A1 Encased food product with contrasting components |
| 04/18/2002 | WO2002030190A1 Method of inactivating viral particles in a blood product |
| 04/18/2002 | WO2002011740A3 'slow release' pharmaceutical compositions comprising lithium carbonate |
| 04/18/2002 | WO2002011697A8 A method of preparing a pharmaceutical composition |
| 04/18/2002 | WO2002009679A3 Use of 13-cis retinoic acid for the treatment of emphysema |
| 04/18/2002 | WO2002007738A8 Combinations of chitosan and psyllium for synergistic adsorption of triglyceride and cholesterol |
| 04/18/2002 | WO2002004570A3 Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
| 04/18/2002 | WO2002000201A3 Method for preparing a composition |
| 04/18/2002 | WO2001091732A3 Medicament for combating respiratory depression |
| 04/18/2002 | WO2001087272A3 Encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 04/18/2002 | WO2001087265A3 Pharmaceutical form of administration for peptides, methods for its production and use |
| 04/18/2002 | WO2001087229A3 Treating infections |
| 04/18/2002 | WO2001085137A3 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| 04/18/2002 | WO2001085136A3 Phospholipid-based powders for drug delivery |
| 04/18/2002 | WO2001085099A3 Polymeric delivery and release systems for oral care actives |
| 04/18/2002 | WO2001078682A3 Sustained release drug compositions |
| 04/18/2002 | WO2001072289A3 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 04/18/2002 | WO2001070288A3 Thermoreversible polymers for delivery and retention of osteoinductive proteins |
| 04/18/2002 | WO2001068075A3 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 04/18/2002 | WO2001062334A3 System and method for preventing sudden cardiac death by nerve sprouting from right stellate ganglion |
| 04/18/2002 | WO2001061007A9 Fibroblast growth factor-23 molecules and uses thereof |
| 04/18/2002 | WO2001060377A3 Methods for treatment of lysosomal storage diseases using biphosphonates |
| 04/18/2002 | WO2001060335A3 Delivery systems using preformed biodegradable polymer compositions and methods |
| 04/18/2002 | WO2001059087A3 Compositions for transfecting nucleic acids and their use |
| 04/18/2002 | WO2001054670A3 Method for coating pharmaceutical dosage forms |
| 04/18/2002 | WO2001052918A3 Fluid delivery device with temperature controlled energy source |
| 04/18/2002 | WO2001051025A3 Formulations of active components in the form of a solid dispersion |
| 04/18/2002 | WO2001045691A3 Method of treating gastrointestinal tract disease with purinergic receptor agonists |
| 04/18/2002 | WO2001043935A3 Injection molding method for neutral and acidic-group containing (meth)acrylate copolymers |
| 04/18/2002 | WO2000073482A9 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
| 04/18/2002 | WO2000071194A9 Method and apparatus for treating a patient |
| 04/18/2002 | WO2000070341A9 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 04/18/2002 | WO2000069942A9 Stabilization and acoustic activation of polymeric micelles for drug delivery |
| 04/18/2002 | WO2000055192A3 Hemocyanin and nucleic acid sequence coding for the same |
| 04/18/2002 | US20020045940 Methods, instruments and materials for chondrocyte cell transplantation |
| 04/18/2002 | US20020045923 Steam generator |
| 04/18/2002 | US20020045883 Substance delivery device |
| 04/18/2002 | US20020045745 Washing starch containing more than 85% amylopectin in order to remove surface-localized proteins, lipids and endotoxins; molecular weight reduction by shearing |
| 04/18/2002 | US20020045734 Geneticaly engineered polypeptide for use drug delivery tools |
| 04/18/2002 | US20020045672 Open pore biodegradable matrices |
| 04/18/2002 | US20020045668 Compositions for sustained release of analgesic agents, and methods of making and using the same |
| 04/18/2002 | US20020045667 Non-toxic antimicrobial compositions and methods of use |
| 04/18/2002 | US20020045665 Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 04/18/2002 | US20020045663 Treating cancer in a patient comprising administering an effective amount of substantially purified D enantiomer of difluoromethylornithine |
| 04/18/2002 | US20020045662 Stable gabapentin having pH within a controlled range |
| 04/18/2002 | US20020045648 Therapeutic compositions comprising excess enantiomer |